Discover a recent study presented at EASL 2025 that explored the impact of opt-out testing for blood-borne viruses in ...

Penetrium™ Achieves Historic Breakthrough Overcoming Cold Tumor Failure and the Challenge of Metastatic Cancer in ...

SCG Cell Therapy Pte Ltd (SCG), a clinical-stage biotechnology company pioneering TCR T cell therapy for infectious diseases and associated cancers, today announced late-breaking clinical data from ...

Immunocore reports first quarter financial results and provides a business update KIMMTRAK® (tebentafusp-tebn) net revenues of $93.9 million in Q1 2025, growing by 33% year-over-year ...

TWO toilet related symptoms could be the first signs of a hard-to-spot cancer that’s on the rise in the UK. Bile duct cancer ...

Introduction: Infection with hepatitis B virus (HBV) and human immunodeficiency virus (HIV) is a public health problem ...

Strategic insight into the Liver Cancer Treatment Market reveals a high-growth opportunity, especially in Asia-Pacific, driven by a rising patient po ...

They have an increased risk of dying from both liver diseases and common diseases such as cancer and cardiovascular ... to Eliminate Transmission of Hepatitis B in Africa Feb. 27, 2025 ...

There is no standard of care for fibrolamellar liver cancer, no targeted therapies. But that may be changing, thanks to ...

The Italian study showed that patients with HCC resulting from viral infections or fatty liver had significantly higher ...

LIVER CANCER, the third leading cause of cancer-related deaths globally, is primarily attributed to hepatocellular carcinoma ...

Gilead Sciences, Inc. (Nasdaq:GILD) today announced new research to be presented at the European Association for the Study of ...